The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.

@article{Barbieri2017TheEO,
  title={The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.},
  author={Christopher E Barbieri and Arul M. Chinnaiyan and Seth P. Lerner and Charles Swanton and Mark A Rubin},
  journal={European urology},
  year={2017},
  volume={71 2},
  pages={237-246}
}
CONTEXT Biomarker-driven cancer therapy, also referred to as precision oncology, has received increasing attention for its promise of improving patient outcomes by defining subsets of patients more likely to respond to various therapies. OBJECTIVE In this collaborative review article, we examine recent literature regarding biomarker-driven therapeutics in urologic oncology, to better define the state of the field, explore the current evidence supporting utility of this approach, and gauge… CONTINUE READING